FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2985492039> ?p ?o ?g. }

• W2985492039 endingPage "356" @default.
• W2985492039 startingPage "350" @default.
• W2985492039 abstract "Abstract Nitric oxide (NO) participates in many physiological and pathological processes in human. Urine tests tell a lot about health, which are convenient and harmless. Redox stress, including imbalance of reactive nitrogen species and its metabolites NOx, has been gaining increased attention in autism spectrum disorder (ASD) research. However, concentrations of urinary nitrite and nitrate among the ASD population stay unclear. In this study, nitrite and nitrate were precisely measured in urine specimens from 44 ASD children, 30 healthy children (the control group) and 28 healthy adults with an optimized and validated analytic method. For the first time, concentrations of urinary NOx in ASD and healthy children were reported. Nitrite in the ASD population is higher than in the control group, with concentrations of 0.8708 ± 0.1121 μM (0.1556–3.0393 μM) and 0.5938 ± 0.07276 μM (0.1134–2.1004 μM) (p = 0.0420), respectively. Nitrite in the adult groups is 0.5808 ± 0.0985 μM (0.0808–1.9335 μM), which is similar to that in the control group. On the contrary, urinary nitrate concentration in ASD children is lower than that in the control group, which are 2.875 ± 0.2716 mM (0.3264–7.1835 mM) and 4.558 ± 0.5915 mM (1.1860–15.8555 mM) (p = 0.0133), respectively. Nitrate in adults is also significantly lower than that in the control, 2.799 ± 0.3640 mM (0.2507–8.6978 mM) and 4.558 ± 0.5915 mM (p = 0.0146), respectively. Nitrite/nitrate ratios for ASD and the control groups were 0.3496 ± 0.04382 x 10-3 and 0.1604 ± 0.01862 x 10-3 (p = 0.0002), which again indicated the probability of NOx as a novel biomarker. Furthermore, no correlation between NOx and gender, as well as sample collection timing was found. Taken together, the association between NOx and ASD was significant. Urinary nitrite, nitrate and NO2-/NO3-, might serve as a new biomarker for ASD diagnosis during pursuit of harmless, fast, and convenient diagnostic method. Further studies are needed for the metabolic pathways of NOx in ASD pathogenesis." @default.
• W2985492039 created "2019-11-22" @default.
• W2985492039 creator A5006165632 @default.
• W2985492039 creator A5037149679 @default.
• W2985492039 creator A5054620758 @default.
• W2985492039 creator A5058956782 @default.
• W2985492039 creator A5067815949 @default.
• W2985492039 creator A5069585223 @default.
• W2985492039 creator A5083417876 @default.
• W2985492039 creator A5084163137 @default.
• W2985492039 creator A5089921012 @default.
• W2985492039 date "2020-01-01" @default.
• W2985492039 modified "2023-10-15" @default.
• W2985492039 title "Urinary NOx, a novel potential biomarker for autism spectrum disorder" @default.
• W2985492039 cites W1660684267 @default.
• W2985492039 cites W1965355582 @default.
• W2985492039 cites W1967027578 @default.
• W2985492039 cites W1967251818 @default.
• W2985492039 cites W1969908029 @default.
• W2985492039 cites W1985227130 @default.
• W2985492039 cites W1990802251 @default.
• W2985492039 cites W1992198528 @default.
• W2985492039 cites W1995330034 @default.
• W2985492039 cites W1997610534 @default.
• W2985492039 cites W2002814861 @default.
• W2985492039 cites W2004160418 @default.
• W2985492039 cites W2009933263 @default.
• W2985492039 cites W2012388298 @default.
• W2985492039 cites W2018959252 @default.
• W2985492039 cites W2030598152 @default.
• W2985492039 cites W2039124237 @default.
• W2985492039 cites W2051876980 @default.
• W2985492039 cites W2059319379 @default.
• W2985492039 cites W2062161568 @default.
• W2985492039 cites W2068893460 @default.
• W2985492039 cites W2079331192 @default.
• W2985492039 cites W2085403321 @default.
• W2985492039 cites W2089509811 @default.
• W2985492039 cites W2094483803 @default.
• W2985492039 cites W2100135154 @default.
• W2985492039 cites W2145724683 @default.
• W2985492039 cites W2172112531 @default.
• W2985492039 cites W2269551280 @default.
• W2985492039 cites W2607139504 @default.
• W2985492039 cites W2804421973 @default.
• W2985492039 cites W2805634078 @default.
• W2985492039 cites W2898816123 @default.
• W2985492039 cites W907004250 @default.
• W2985492039 doi "https://doi.org/10.1016/j.freeradbiomed.2019.11.001" @default.
• W2985492039 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31706990" @default.
• W2985492039 hasPublicationYear "2020" @default.
• W2985492039 type Work @default.
• W2985492039 sameAs 2985492039 @default.
• W2985492039 citedByCount "5" @default.
• W2985492039 countsByYear W29854920392021 @default.
• W2985492039 countsByYear W29854920392022 @default.
• W2985492039 countsByYear W29854920392023 @default.
• W2985492039 crossrefType "journal-article" @default.
• W2985492039 hasAuthorship W2985492039A5006165632 @default.
• W2985492039 hasAuthorship W2985492039A5037149679 @default.
• W2985492039 hasAuthorship W2985492039A5054620758 @default.
• W2985492039 hasAuthorship W2985492039A5058956782 @default.
• W2985492039 hasAuthorship W2985492039A5067815949 @default.
• W2985492039 hasAuthorship W2985492039A5069585223 @default.
• W2985492039 hasAuthorship W2985492039A5083417876 @default.
• W2985492039 hasAuthorship W2985492039A5084163137 @default.
• W2985492039 hasAuthorship W2985492039A5089921012 @default.
• W2985492039 hasConcept C105923489 @default.
• W2985492039 hasConcept C118552586 @default.
• W2985492039 hasConcept C126322002 @default.
• W2985492039 hasConcept C178790620 @default.
• W2985492039 hasConcept C185592680 @default.
• W2985492039 hasConcept C203032635 @default.
• W2985492039 hasConcept C205778803 @default.
• W2985492039 hasConcept C2778538070 @default.
• W2985492039 hasConcept C2781197716 @default.
• W2985492039 hasConcept C54355233 @default.
• W2985492039 hasConcept C71924100 @default.
• W2985492039 hasConcept C77411442 @default.
• W2985492039 hasConcept C86803240 @default.
• W2985492039 hasConceptScore W2985492039C105923489 @default.
• W2985492039 hasConceptScore W2985492039C118552586 @default.
• W2985492039 hasConceptScore W2985492039C126322002 @default.
• W2985492039 hasConceptScore W2985492039C178790620 @default.
• W2985492039 hasConceptScore W2985492039C185592680 @default.
• W2985492039 hasConceptScore W2985492039C203032635 @default.
• W2985492039 hasConceptScore W2985492039C205778803 @default.
• W2985492039 hasConceptScore W2985492039C2778538070 @default.
• W2985492039 hasConceptScore W2985492039C2781197716 @default.
• W2985492039 hasConceptScore W2985492039C54355233 @default.
• W2985492039 hasConceptScore W2985492039C71924100 @default.
• W2985492039 hasConceptScore W2985492039C77411442 @default.
• W2985492039 hasConceptScore W2985492039C86803240 @default.
• W2985492039 hasLocation W29854920391 @default.
• W2985492039 hasOpenAccess W2985492039 @default.
• W2985492039 hasPrimaryLocation W29854920391 @default.
• W2985492039 hasRelatedWork W2332142175 @default.
• W2985492039 hasRelatedWork W2341713766 @default.

• next